Breen Joseph T, Carlson Matthew L, Link Michael J, Moore Eric J, Neff Brian A, Driscoll Colin L W
Department of Otorhinolaryngology - Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, United States.
J Neurol Surg B Skull Base. 2012 Dec;73(6):371-8. doi: 10.1055/s-0032-1322797. Epub 2012 Aug 29.
Objective Describe the clinical course and outcomes of patients with primary acinic cell carcinoma (ACC) of the parotid gland with skull base invasion or metastasis. Design Retrospective case series (1995-2011) at a single institution. Results Ten patients met study criteria. Mean and median time from initial diagnosis of parotid ACC to development of skull base disease were 14.6 and 10.2 years, respectively. Two patients demonstrated skull base disease on initial presentation. Those who pursued further treatment after developing disease at the skull base underwent surgery (4/7), stereotactic radiosurgery (4/7), or external beam radiation (3/7). The 10-year Kaplan-Meier estimated overall survival after initial diagnosis of parotid ACC was 80%. Once skull base invasion occurred, 2-year estimated overall survival was 50%. Conclusion Although primary ACC of the parotid generally caries an excellent prognosis, tumor control with cranial base disease is difficult and the majority of patients present with late aggressive recurrences. Our observations underscore the importance of long-term follow-up in this patient group.
描述腮腺原发性腺泡细胞癌(ACC)伴颅底侵犯或转移患者的临床病程及预后。设计:单机构回顾性病例系列研究(1995 - 2011年)。结果:10例患者符合研究标准。从腮腺ACC初诊至颅底病变发生的平均时间和中位时间分别为14.6年和10.2年。2例患者初诊时即有颅底病变。在颅底出现病变后接受进一步治疗的患者接受了手术(4/7)、立体定向放射外科治疗(4/7)或外照射放疗(3/7)。腮腺ACC初诊后10年的Kaplan-Meier估计总生存率为80%。一旦发生颅底侵犯,2年估计总生存率为50%。结论:尽管腮腺原发性ACC总体预后良好,但控制颅底病变困难,大多数患者出现晚期侵袭性复发。我们的观察结果强调了该患者群体长期随访的重要性。